Clinical Trial Update: RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of RV001V, a RhoC anticancer vaccine, for metastasis prevention in prostate cancer completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• RV001V (RhoC anticancer vaccine)

Snippet

Sponsor: RhoVac APS | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-06-09